Collate raises $95M as life sciences document workflows get an AI upgrade
Collate’s $95 million round points to growing demand for AI tools that can handle complex, regulated document workflows in life sciences.
Life sciences teams do not just need smarter AI; they need AI that can survive messy, regulated workflows. Collate’s raise points to a market where document-heavy work is becoming a serious automation target.
What happened
Collate raised $95 million to expand its work on AI-powered document automation for life sciences organisations. The company is focused on helping teams manage complex documentation, review processes, and knowledge workflows.
Why it matters
Life sciences companies deal with huge volumes of sensitive and technical documents. If AI can reduce manual work while keeping accuracy and compliance intact, it could become a valuable layer inside research, regulatory, and operational teams.
The bigger picture
Enterprise AI is becoming more vertical. Instead of generic assistants, the stronger opportunities may sit inside specific industries where workflows are painful, valuable, and difficult to automate with one-size-fits-all software.